Neutropenia as a Complication of High-Dose Intravenous Immunoglobulin Therapy in Adult Patients with Neuroimmunologic Disorders

Clinical Neuropharmacology

Volumn 26, Issue 6, 2003, Pages 306-311

  Matsuda, Masayuki ^a   Hosoda, Waki ^a   Sekijima, Yoshiki ^a   Hoshi, Kenichi ^a   Hashimoto, Takao ^a   Itoh, Susumu ^a   Ikeda, Shu Ichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD11b; CD16; Corticosteroid; Flow cytometry; High dose immunoglobulin therapy; Neuroimmunologic disorder; Neutropenia

Indexed keywords

CD11B ANTIGEN; CD16 ANTIGEN; CORTICOSTEROID; IMMUNOGLOBULIN; PREDNISOLONE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; DERMATOMYOSITIS; DRUG MEGADOSE; FEMALE; FLOW CYTOMETRY; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOTHERAPY; LEUKOCYTE COUNT; MALE; NEUROLOGIC DISEASE; NEUTROPENIA; POLYMYOSITIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD11B; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; ERYTHROCYTE COUNT; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS, INTRAVENOUS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; NEUTROPENIA; NEUTROPHILS; PREDNISOLONE; RECEPTORS, IGG;

EID: 0345601085     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-200311000-00009     Document Type: Article

References (23)

1. Mendell JR, Barohn RJ, Freimer ML, et al. Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 2001;56:445-449.
2. Dalakas MC. Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: present status and practical therapeutic guidelines. Muscle Nerve. 1999;22:1479-1497.
3. Stangel M, Hartung HP, Marx P, et al. Intravenous immunoglobulin treatment of neurological autoimmune diseases. J Neurol Sci. 1998; 153:203-214.
4. Sater RA, Rostami A. Treatment of Guillain-Barré Syndrome with intravenous immunoglobulin. Neurology. 1998;51(Suppl. 5):S9-15.
5. Fazekas F, Deisenhammer F, Strasser-Fuchs S, et al. Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Lancet. 1997;349: 589-593.
6. Dalakas MC. Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis. Neurology. 1998;51(Suppl. 5):S37-S45.
7. Dalakas MC. Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases. Neurology. 1998;51(Suppl. 5):S2-S8.
8. Majer RV, Green PJ. Neutropenia caused by intravenous immunoglobulin. Br J Med. 1988;296:1262. (Letter)
9. Veys PA, Macey MG, Owens CM, et al. Neutropenia following intravenous immunoglobulin. Br J Med. 1988;296:1800. (Letter)
10. Ben-Chetrit E, Putterman C. Transient neutropenia induced by intravenous immune globulin. N Engl J Med. 1992;326:270-271. (Letter)
11. Bower LR III, Brey RL, Rogers SJ, et al. Intravenous immunoglobulin-induced neutropenia. Ann Neurol. 1994;36:291. (Abstract)
12. Tam DA, Morton LD, Stroncek DF, et al. Neutropenia in a patient receiving intravenous immune globulin. J Neuroimmunol. 1996;64: 175-178.
13. Brannagan TH III, Nagle KJ, Lange DJ, et al. Complications of intravenous immune globulin treatment in neurologic disease. Neurology. 1996;47:674-677.
14. Berkovitch M, Dolinski G, Tauber T, et al. Neutropenia as a complication of intravenous immunoglobulin (IVIG) therapy in children with immune thrombocytopenic purpura: common and nonalarming. Int J Immunopharmacol. 1999;21:411-415.
15. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology. 1991; 41:617-618.
16. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol. 1990;27(Suppl): S21-S24.
17. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med. 1975;292:344-347.
18. Odaka M, Yuki N, Hirata K. Anti-GQ1b antibody syndrome. Clinical and immunological range. J Neurol Neurosurg Psychiatry. 2001;70:50-55.
19. Blanchette VS, Kirby MA, Turner C. Role of IVIG in autoimmune hematologic disorders. Semin Hematol. 1992;29:72-78.
20. Lalezari P, Khorshidi M, Petrosova M. Autoimmune neutropenia of infancy. J Pediatr. 1986;109:764-769.
21. O'Donnell JL, Roberts-Thompson PJ, Ahern MJ, et al. Alteration in circulating neutrophil CR3 density associated with immunoglobulin infusion. Austral N Zeal J Med. 1988;18:95-100.
22. Kurlander RJ, Ellison DM, Hall J. The blockade of Fc receptor-mediated clearance of immune complexes in vivo by a monoclonal antibody (2.4G2) directed against Fc receptors on murine leukocytes. J Immunol. 1984;133:855-862.
23. Clarkson SB, Kimberly RP, Bussel JB, et al. Blockade of immune complex clearance by a monoclonal antibody. Clin Res. 1985;33: 1587A. (abstract)